Previous 10 | Next 10 |
Guided Therapeutics ( OTCQB:GTHP ) ships four LuViva Advanced Cervical Scan systems and associated disposables to its Chinese co-manufacturing partner and distributor for China, Shandong Yaohua Medical Instrument Corporation. More news on: Guided Therapeutics, Inc., Healthcare s...
Books Nearly $77,000 in Revenue from Transaction Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had shipped four LuViva Advanced Cervical Scan systems and associated disposables...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced that it will meet with the FDA to finalize the protocol for its clinical study in support of its Premarketing Application for the L...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today that it had submitted its protocol to FDA for a clinical study to support marketing of the LuViva® Advanced Cervical Sca...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that its common stock is now listed for trading on the Over the Counter Venture Market (OTCQB) Exchange. The stock formerly traded on the P...
Company Partners with Newmars Technologies, Kft. for Cost Effective Contract Manufacturing in Hungary Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that its flagship product, the L...
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today that it had completed a Series E Convertible Preferred Stock Offering in the amount of $1.5 Million. The financing was ...
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for marketing approval in China. The Compa...
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today it had held a scheduled teleconference on April 28, 2020 with the US FDA as the next step for obtaining sales and marke...
New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cervical Cancer Diagnostic Test Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer...
News, Short Squeeze, Breakout and More Instantly...
Guided Therapeutics Inc Company Name:
GTHP Stock Symbol:
OTCMKTS Market:
Guided Therapeutics Inc Website:
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that leading physicians from four prestigious medical centers have completed their review and signed off on the study results for submission to the Chinese National Medical Products Administra...
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...